Xcout Intel
Asceneuron competitors & alternatives
The 12 closest competitors and alternatives to Asceneuron among biotechnology companies — ranked by similarity to what Asceneuron actually does, not by market-cap band.
Subscribe to see Asceneuron’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Asceneuron
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Asceneuron at a glance
Asceneuron is a biotechnology company headquartered in Switzerland, founded in 2012. It has raised at least $130.7M across the 2 funding rounds on record. Its most recent funding round, Series C, raised $100M in July 2024. Xcout tracks 1 named person at Asceneuron, including Abbas Hussain (Chair).
Asceneuron leadership
- Abbas HussainChair
Asceneuron funding rounds
At least $130.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $100M | 8 named | |
| Grant | $30.7M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Asceneuron competitors
Ranked by semantic similarity — how close each company is to Asceneuron by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Argo Therapeutics is a Swiss biotechnology company headquartered in Allschwil, Switzerland, focused on neurodegenerative-disease therapeutics.
Similar biotechnology company
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Similar biotechnology company
Aspen Neuroscience, Inc. is a clinical-stage private biotechnology company headquartered in San Diego, California. The company focuses on developing personalized autologous cell therapies for neurodegenerative diseases.
Similar biotechnology company
CuraSen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies to treat neurodegenerative diseases by targeting specific receptor systems in the brain. The company's scientific approach focuses on restoring neurovascular and neuronal function to serve patients suffering from conditions such as Parkinson's disease and other neurodegenerative disorders.
Similar biotechnology company
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Similar biotechnology company
Neurasic Therapeutics is a biotechnology company headquartered in Montreal, Canada, created to advance groundbreaking research into novel therapeutics.
Similar biotechnology company
Neurona Therapeutics Inc. is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Biotech
AcuraStem Inc. is a biotechnology company founded in 2016 and headquartered in Pasadena, California, focused on developing potential therapies for neurodegenerative diseases like ALS.
Life Sciences
EXCIVA GmbH is a privately held biotechnology company established in 2016 in Heidelberg, Germany, focused on developing clinical-stage therapeutics to improve quality of life and treat Alzheimer's disease.
Life Sciences
Rejuveron Life Sciences AG is a biotechnology company headquartered in Schlieren, Switzerland, focused on developing innovative therapeutics and therapies for aging-related diseases and longevity.
Biotech
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Similar biotechnology company
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Asceneuron and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Asceneuronand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →